Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMountview Est. Regulatory News (MTVW)

Share Price Information for Mountview Est. (MTVW)

Share Price is delayed by 15 minutes
Get Live Data
9,000.00    0.00 (0.00%)
Bid:
8,800.00
Ask:
9,000.00
Spread: 200.00 (2.273%)
Market Cap: £350.91m
MTVW Live PriceLast checked at - London Stock Exchange

Intraday Mountview Est. Share Chart

Director Share Purchase

3 Apr 2017 07:00

RNS Number : 2723B
Mountview Estates PLC
03 April 2017
 

3 APRIL 2017

MOUNTVIEW ESTATES P.L.C.

 

 

Mountview Estates P.L.C.

("Mountview" or "the Company")

 

Director Share Purchase

 

Mountview Estates P.L.C. was informed on 31 March 2017 that, on the same day, Sinclair Estates Limited entered into an agreement, conditional on a grant of probate, to purchase 36,000 ordinary shares of 5p each ("Ordinary Shares") at a price of £110.41 per share. Duncan Sinclair, the Company's Chief Executive Officer is also a director of Sinclair Estates Limited.

 

Following this share purchase, Duncan Sinclair's total beneficial interest in the Company will be 574,383 Ordinary Shares, representing 14.73 per cent of the Company's total voting rights.

 

Ends

 

For further information on the Company, visit: www.Mountviewplc.co.uk

 

 

SPARK Advisory Partners Limited (Financial Adviser)

www.Sparkadvisorypartners.com

Miriam Greenwood

0203 368 3553

Mark Brady

0203 368 3551

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

(Disclosure in relation to purchase of Ordinary Shares)

 1 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Duncan Sinclair (A director of Sinclair Estates Limited)

2

Reason for the notification 

a)

Position/status 

Chief Executive Officer

b)

Initial notification /Amendment 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name 

Mountview Estates P.L.C.

b)

LEI

213800CWH9IB4DTEYG96

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument 

Identification code 

Ordinary Shares 5p each

 

GB0006081037

b)

Nature of the transaction 

Purchase of ordinary shares

c)

Price(s) and volume(s)

 

 Price(s) 

Volume(s)

£110.41

36,000

 

d)

 

Aggregated information 

 

N/A

e)

Date of the transaction 

31 March 2017

f)

Place of the transaction 

Off Market

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUURVRBVASRAR
Date   Source Headline
26th May 202610:27 amRNSUpdate on General Meeting voting outcome
20th Apr 202611:00 amRNSHolding(s) in Company
20th Apr 202610:59 amRNSHolding(s) in Company
20th Apr 202610:58 amRNSHolding(s) in Company
31st Mar 202611:05 amRNSDirector/PDMR Shareholding
30th Mar 20266:30 pmRNSDividend Payment Delay
25th Mar 20265:04 pmRNSDirector/PDMR Shareholding
25th Mar 202610:01 amRNSDirector/PDMR Shareholding
19th Mar 202610:02 amRNSDirector/PDMR Shareholding
18th Mar 202612:29 pmRNSDirector/PDMR Shareholding
25th Feb 20264:21 pmRNSDirector/PDMR Shareholding
23rd Feb 202612:49 pmRNSDirector/PDMR Shareholding
12th Feb 202612:03 pmRNSDirector/PDMR Shareholding
10th Feb 20264:28 pmRNSDirector/PDMR Shareholding
9th Feb 202611:16 amRNSDirector/PDMR Shareholding
26th Jan 20263:38 pmRNSBoard Committee change
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2025
17th Nov 202512:15 pmRNSResult of General Meeting
22nd Oct 202512:00 pmRNSNotice of General Meeting
17th Oct 202512:22 pmRNSDirector/PDMR Shareholding
16th Oct 20251:04 pmRNSDirector/PDMR Shareholding
15th Oct 20254:29 pmRNSDirector/PDMR Shareholding
1st Oct 20251:16 pmRNSDirector/PDMR Shareholding
15th Aug 20257:03 amRNSBoard changes
13th Aug 20251:46 pmRNSResult of Annual General Meeting
30th Jul 20255:10 pmRNS2025 Annual Report and Accounts
24th Jul 202512:32 pmRNSDirector/PDMR Shareholding
22nd Jul 20251:05 pmRNSDirector/PDMR Shareholding
17th Jul 20255:20 pmRNSDirector/PDMR Shareholding
11th Jul 202511:22 amRNSPublication of 2025 Annual Report & Notice of AGM
19th Jun 20257:00 amRNSPreliminary Results: year ended 31 March 2025
16th May 20257:00 amRNSUpdate on General Meeting voting outcome
31st Mar 20257:00 amRNSDirectorate change – Contract Extension
26th Mar 202512:02 pmRNSDirector/PDMR Shareholdings
28th Feb 20255:25 pmRNSDirector/PDMR Shareholding
14th Feb 20257:00 amRNSUpdate on 2024 Annual General Meeting outcome
21st Nov 20242:09 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2024
19th Nov 20249:59 amRNSDirectorate Change
18th Nov 202412:07 pmRNSResult of General Meeting
23rd Oct 202412:00 pmRNSNotice of General Meeting
19th Sep 20246:11 pmRNSDirector/PDMR Shareholding
14th Aug 20241:37 pmRNSResult of Annual General Meeting
23rd Jul 20248:58 amRNSPublication of 2024 Annual Report and Accounts
12th Jul 20249:31 amRNSAnnual Financial Report and Notice of AGM
20th Jun 20247:00 amRNSPreliminary Results: year ended 31 March 2024
20th May 20247:00 amRNSUpdate on General Meeting voting outcome
14th Mar 20242:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.